Abstract:Background: Renal fibrosis is the final common pathway of chronic kidney disease (CKD), which is clinically irreversible and without effective therapy. Renal tubules are vulnerable to various insults, and tubular injury is involving in the initiation and evolution of renal inflammation and fibrosis. Neurokinin-1 receptor (NK-1R) functions by interacting with proinflammatory neuropeptide substance P (SP), exerting crucial roles in various neurological and non-neurological diseases. However, its roles in renal inflammation and fibrosis are still unknown. Methods: We collected renal biopsy specimens and serum samples of individuals with or without CKD. Additionally, knockout mice lacking NK-1R expression, SP addition and NK-1R pharmacological antagonist treatment in the unilateral ureteral obstruction (UUO) model, and NK-1R-overexpressed HK-2 cells were employed. Results: Renal SP/NK-1R and serum SP were increased in patients with CKD and mice experiencing UUO and correlated with renal fibrosis and function. SP addition enhanced UUO-induced progressive inflammatory responses and renal fibrosis, whereas genetically or pharmacologically targeting NK-1R attenuated these effects. Mechanistically, TFAP4 promoted NK-1R transcription by binding to its promoter, which was abolished by mutation of the binding site between TFAP4 and NK-1R promoter. Furthermore, SP acted through the NK-1R to activate the JNK/p38 pathways to modulate cell fate of tubular epithelial cells including growth arrest, apoptosis, and expression of profibrogenic genes. Conclusion: Our data reveals that SP/NK-1R signaling promotes renal inflammatory responses and fibrosis, suggesting NK-1R could be a potential therapeutic target for the patients with CKD.

Nuclear receptors in renal health and disease

The Research Advance of Nuclear Hormone Receptors in Immune Regulation

The renal damage and mechanisms relevant to antitumoral drugs

Novel insights into NOD-like receptors in renal diseases

Emerging Roles Of Long Non-Coding Rnas In Renal Fibrosis

Targeting NR1D1 in organ injury: challenges and prospects

NMDA Receptor-mediated CaMKII/ERK Activation Contributes to Renal Fibrosis

The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis

Kidney Disease Models: Tools to Identify Mechanisms and Potential Therapeutic Targets

A comprehensive data mining study shows that most nuclear receptors act as newly proposed homeostasis-associated molecular pattern receptors

Single-cell transcriptomics and chromatin accessibility profiling elucidate the kidney-protective mechanism of mineralocorticoid receptor antagonists

Estrogen and estrogen receptors in kidney diseases

The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation

Nuclear Receptor Variants in Liver Disease

Insights into the Molecular Mechanisms of NRF2 in Kidney Injury and Diseases

Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma

Epigenetics of Hypertensive Nephropathy

Targeting NK-1R attenuates renal fibrosis via modulating inflammatory responses and cell fate in chronic kidney disease

Roles of Nrf2 in Protecting the Kidney from Oxidative Damage

Long Non-coding RNA: An Emerging Contributor and Potential Therapeutic Target in Renal Fibrosis